The intent of the FY14 PH/TBIRP Investigational Treatments for TBI and PTSD Clinical Trial Award (ITTPCTA) is to address Section 704 of the National Defense Authorization Act for Fiscal Year 2014, which directs a pilot program and establishment of a process for randomized placebo-controlled clinical
trials of investigational treatments (including diagnostic testing) of TBI and PTSD received by members of the Armed Forces in health care facilities other than military treatment facilities.